Is Hypermobile EDS Hereditary? Family and Child Evaluation
At a Glance
Hypermobile EDS often runs in families, but its gene is unknown, so no genetic test can confirm it or predict which child will inherit it. Relatives and children should be assessed when they have ongoing symptoms, while warning signs may warrant genetic counseling.
In this answer
3 sections
Yes, hypermobile Ehlers-Danlos syndrome (hEDS) often runs in families and is considered hereditary. It generally appears to be passed down in an autosomal dominant pattern [1] [2]. In conditions with a known autosomal dominant gene, this means each child has a 50% chance of inheriting the genetic trait. However, because the specific gene (or genes) responsible for hEDS have not yet been discovered, this 50% risk is an estimate, and there is currently no genetic test that can predict or confirm if a child has inherited hEDS [3] [2].
It is also completely normal to feel stressed about the uncertainty of passing this condition to your children. While there is no prenatal test for hEDS, a genetic counselor can still help you understand your family history and discuss what information to share with relatives [4].
How hEDS Appears in Families
Because there is no confirmatory genetic test, hEDS is diagnosed using the strict 2017 international clinical criteria [2]. These criteria require a combination of generalized joint hypermobility, specific physical features or a family history, and the exclusion of other medical conditions [5].
While the condition clusters in families, how it affects each person can vary significantly—even among closely related individuals [6]. This is known as variable expression. One family member might experience severe joint pain, frequent dislocations, and chronic fatigue, while another might just be very flexible with few or no negative symptoms [6]. Inheriting a genetic predisposition is not the same as developing severe symptoms, and being flexible without pain or complications does not necessarily mean someone has a medical disorder.
Should Relatives and Children Be Checked?
You do not need to rush every flexible family member to a specialist. However, family members should be evaluated by a primary care doctor or pediatrician if they are experiencing persistent symptoms like recurrent joint dislocations, chronic pain, or frequent sprains [1] [7].
- Adult Relatives: Having a confirmed hEDS diagnosis in a first-degree relative (a parent, full sibling, or child) is one part of the official 2017 hEDS diagnostic criteria. However, your relative must still be independently assessed to see if they meet the full criteria themselves [5] [8]. A relative might instead be diagnosed with hypermobility spectrum disorder (HSD). HSD is a real, clinically important condition that can cause significant pain and disability, but it is classified separately from hEDS. Because they are distinct classifications under the 2017 criteria, an HSD diagnosis in a relative does not fulfill the specific family-history requirement for your own hEDS diagnosis [9] [1].
- Children: Diagnosing children with hEDS is handled differently because the adult criteria are difficult to apply to growing bodies. Pediatricians use a specific framework to evaluate children for generalized joint hypermobility—often using a Beighton score (a flexibility test) of 6 or higher out of 9—alongside other symptoms [10]. A formal hEDS diagnosis is usually reserved for adolescents who have reached “biological maturity” (the end of puberty and growth) [11] [10]. However, a child never has to wait for an official hEDS label to receive medical care, physical therapy, or pain management for their symptoms [10].
When is Genetic Counseling Recommended?
Because there is no known genetic mutation for hEDS, routine genetic testing is not recommended just to confirm hEDS or HSD [12] [13].
However, genetic counseling and testing are appropriate if you or your family members show “red flags” that point to a different, potentially more serious connective tissue disorder, such as vascular EDS, Marfan syndrome, or Loeys-Dietz syndrome [12] [14].
Warning signs that warrant a referral to a clinical geneticist include:
- A family history of sudden, unexplained early death or early vascular issues (such as arterial, intestinal, or uterine ruptures) [12]
- Severe skin fragility, marked atrophic (sunken or cigarette-paper-like) scarring, or unusual tissue tearing [14] [15]
- Significant skeletal deformities, lens dislocation in the eye, or physical features typical of other genetic syndromes [14] [16]
(Note: Sudden severe chest, abdominal, or back pain, fainting, or stroke-like symptoms require immediate emergency care, not a routine genetics appointment.)
In a study of one specialized genetics clinic, about 26% of patients referred who met the clinical criteria for hEDS were actually found to have an alternative or additional genetic diagnosis when tested [8]. While this high percentage reflects a specialty clinic that sees complex cases and does not mean 1 in 4 people with hEDS in the general population are misdiagnosed, it highlights the importance of genetic testing when specific warning signs are present.
Common questions in this guide
Is hypermobile Ehlers-Danlos syndrome hereditary?
Can a genetic test tell whether my child has hEDS?
Should my first-degree relatives be evaluated for hEDS?
How is hEDS assessed in children?
When should my family seek genetic counseling or testing?
Does a relative with hypermobility spectrum disorder count as family history for hEDS?
Related questions
Show more
Get notified when new evidence is published on hypermobility syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew KS, Kamps-Schmitt KA, Borge R
American family physician 2021; (103(8)):481-492.
PMID: 33856167 - 2
The Many Facets of Hypermobile Ehlers-Danlos Syndrome.
Riley B
The Journal of the American Osteopathic Association 2020; (120(1)):30-32 doi:10.7556/jaoa.2020.012.
PMID: 31904772 - 3
Biological insights in the pathogenesis of hypermobile Ehlers-Danlos syndrome from proteome profiling of patients' dermal myofibroblasts.
Chiarelli N, Zoppi N, Ritelli M, et al.
Biochimica et biophysica acta. Molecular basis of disease 2021; (1867(4)):166051 doi:10.1016/j.bbadis.2020.166051.
PMID: 33383104 - 4
Assessment of the beliefs, needs, and expectations for genetic counseling of patients with hypermobile Ehlers-Danlos syndrome.
Ahimaz P, Kramer T, Swaroop P, et al.
American journal of medical genetics. Part A 2022; (188(11)):3172-3183 doi:10.1002/ajmg.a.62945.
PMID: 36209348 - 5
Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
Miller AJ, Stiles LE, Sheehan T, et al.
Autonomic neuroscience : basic & clinical 2020; (224()):102637 doi:10.1016/j.autneu.2020.102637.
PMID: 31954224 - 6
Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
Chiarelli N, Zoppi N, Venturini M, et al.
Cells 2021; (10(11)) doi:10.3390/cells10113236.
PMID: 34831458 - 7
Age-related symptom clustering in pediatric hypermobility spectrum disorders: a scoping review.
Pochcial P, Solomon SC, Bruno KA, et al.
Orphanet journal of rare diseases 2026; (21(1)).
PMID: 42218552 - 8
Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing.
Forghani I, See J, McGonigle WC
Genes 2025; (16(5)) doi:10.3390/genes16050530.
PMID: 40428350 - 9
Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
Ritelli M, Chiarelli N, Cinquina V, et al.
American journal of medical genetics. Part A 2024; (194(2)):174-194 doi:10.1002/ajmg.a.63426.
PMID: 37774134 - 10
Pediatric joint hypermobility: a diagnostic framework and narrative review.
Tofts LJ, Simmonds J, Schwartz SB, et al.
Orphanet journal of rare diseases 2023; (18(1)):104 doi:10.1186/s13023-023-02717-2.
PMID: 37143135 - 11
[Pediatrics. Diagnosis of generalized joint hypermobility in children].
Bregou A, Bonafé L, Rohrbach M, Garcia Segarra N
Revue medicale suisse 2025; (21(903)):200-204 doi:10.53738/REVMED.2025.21.903.200.
PMID: 39881647 - 12
Hypermobile Ehlers Danlos for the Primary Care Provider.
White L, Procknow SS
Missouri medicine 2024; (121(4)):289-296.
PMID: 39575079 - 13
Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.
Scicluna K, Formosa MM, Farrugia R, Borg I
Clinical genetics 2022; (101(1)):20-31 doi:10.1111/cge.14026.
PMID: 34219226 - 14
Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.
Colombi M, Dordoni C, Chiarelli N, Ritelli M
American journal of medical genetics. Part C, Seminars in medical genetics 2015; (169C(1)):6-22 doi:10.1002/ajmg.c.31429.
PMID: 25821090 - 15
Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
Gensemer C, Burks R, Kautz S, et al.
Developmental dynamics : an official publication of the American Association of Anatomists 2021; (250(3)):318-344 doi:10.1002/dvdy.220.
PMID: 32629534 - 16
International Perspectives on Joint Hypermobility: A Synthesis of Current Science to Guide Clinical and Research Directions.
Nicholson LL, Simmonds J, Pacey V, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(6)):314-320 doi:10.1097/RHU.0000000000001864.
PMID: 35661088
This page is for informational purposes only and does not constitute medical advice about hEDS or your family. A primary care clinician, pediatrician, or genetic counselor can help interpret symptoms, family history, and referrals.